Billing and Coding: Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin

This article provides billing and coding guidance that supplements LCD L39396 for allogeneic hematopoietic cell transplantation for primary refractory or relapsed Hodgkin's lymphoma and relapsed/refractory B-cell or T-cell non-Hodgkin's lymphoma. It references and defers to CMS NCD 110.23 for nationally covered indications and describes additional locally covered indications without repeating NCD details.

"Allogeneic hematopoietic cell transplantation is covered for primary refractory or relapsed Hodgkin's lymphoma and relapsed or refractory non-Hodgkin's lymphoma of B-cell or T-cell origin as an add..."

Sign up to see full coverage criteria, indications, and limitations.